Drug delivery systems for vaginal infections

Sandra Cristina Ferreira Borges, Joana Barbosa, Paula Teixeira*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

13 Downloads

Abstract

Vaginal infections are one of the most common gynecological problems. The lower female genital tract can be infected by various pathogens such as virus (human immunodeficiency virus, HIV), bacteria (Gardnerella vaginalis), fungi (Candida spp.) or parasites (Trichomonas vaginalis).
The vagina has been the local for the delivery of therapeutic agents. Depending on the antimicrobial agents, different dosage forms have been developed, comprising douches, creams, ointments, gels, foams, tablets, ovules, rings, tampons and, more recently, vaginal films. Innovative approaches, like encapsulation technologies, have emerged in an attempt to overcome the several limitations of the existing systems for vaginal administration of therapeutic agents.
This review explores the antimicrobial agents that can be used for vaginal infections therapy, the various vaginal dosage forms to deliver these therapeutic agents, their advantages and limitations and the novel advances in the area of vaginal drug delivery.
Original languageEnglish
Title of host publicationFrontiers in clinical drug research-anti infectives
EditorsAtta ur Rahman
PublisherBentham Science Publishers B.V.
Chapter7
Pages233-258
Number of pages26
ISBN (Electronic)978-1-68-108153-3
Publication statusPublished - 2015

Keywords

  • vaginal infection
  • antimicrobials
  • therapeutic systems
  • vaginal dosage forms
  • encapsulation

Fingerprint

Dive into the research topics of 'Drug delivery systems for vaginal infections'. Together they form a unique fingerprint.

Cite this